Nanogen Pharmaceutical Biotechnology JSC
Nanogen Pharmaceutical Biotechnology JSC
🇻🇳 Vietnam, Ho Chi Minh City (HCMC)
1997501-1000 peopleManufacturer/DistributorNanogen Pharmaceutical Biotechnology JSC is a pioneering biopharmaceutical manufacturer headquartered in Ho Chi Minh City, Vietnam. Established in 1997, the company has grown into a leading research and innovation-driven enterprise with a workforce of 501 to 1,000 employees. Nanogen operates four advanced manufacturing plants and a dedicated R&D center, maintaining high-quality standards with WHO-GMP and TGA-GMP (Australia) certifications. The company specializes in the development and production of Active Pharmaceutical Ingredients (API), biosimilars, and finished dosage forms, including lyophilized powders, vials, and prefilled syringes.
Their extensive product portfolio focuses on critical therapeutic areas such as Hepatitis B and C treatments, cancer therapeutics, and anemia management. Notable products include PEGNANO, the first biosimilar of its kind in Asia, as well as FACEPTOR and MIRACEL for various oncology applications. Beyond its proprietary product lines, Nanogen provides comprehensive Contract Manufacturing Organization (CMO) and OEM services, leveraging state-of-the-art bioreactor purification systems. The company has a significant international footprint, exporting biological therapies and vaccines to over 15 countries across Asia, Europe, Africa, and the Americas. Nanogen is also recognized for its advanced innovation in vaccine development, notably progressing the NANO COVAX Covid-19 vaccine through Phase 3 clinical trials.
OEM manufacturerOffers OEM services for customized brand manufacturing.
Own brandOwns and operates its own brands and manufacturing facilities.
High capacity factoryCan handle large-scale or bulk production orders.
Patented technologyHolds multiple product or process patents.
Contact
**********************
2
*************
1
Products
Ficocyte
NANOTOX
Pegnano
Covid-19 innovation
NANOTOX
Contract manufacturing organization
Interferon alfa-2a
Contract manufacturing organization
Customers
HEALTHCARE PHARMACEUTICALS
**********************
***********************
***************
**************
Unlock all 21 customers
Certifications
GMP2
Ask AI about this supplier
Key export market
Shipments
Shipments count
0
Export volume
0 kg
Export countries
0
Customers
0
Insights
Top 5 customers
Reflecting the depth of cooperation between supplier and customersTop 5 customers
This insight is only available in the Pro planTop 5 export countries
Reflecting the supplier's export experience in target countriesTop 5 export countries
This insight is only available in the Pro planShipment count distribution
Reflecting the supplier's market business activityAll categories
Shipment count distribution
This insight is only available in the Pro planExport weight distribution (kg)
Reflecting the supplier's export scaleAll categories
Export weight distribution (kg)
This insight is only available in the Pro planExport weight trend (kg)
Reflecting the growth rate of the supplier's phased total supply volume and the fluctuation of supply volume, identifying supply peaks and troughsAll categories
Export weight trend (kg)
This insight is only available in the Pro planCIF trend (USD)
For identifying high-value cooperation periods and single order value changesAll categories
CIF trend (USD)
This insight is only available in the Pro planSimilar suppliers you may like
Nanogen Company Limited
🇻🇳 Vietnam
200811-50 peopleManufacturerExperienced exporter
Multi-country export
Shipments
1845
Key customer
MASTER LOGISTICS
Key market
🇦🇪 United Arab Emirates
Description
Nanogen Company Limited is a specialized manufacturer and supplier based in Ho Chi Minh City, Vietnam, dedicated to the animal nutrition industry. Established as a key player in the livestock sector, the company focuses on the production and distribution of high-quality animal feed, cattle feed, and various feed supplements. With a workforce of between 11 and 50 employees, Nanogen Company Limited operates manufacturing facilities to serve the growing demands of the livestock and cattle markets. Their product portfolio is centered on animal nutrition products designed to support the health and productivity of livestock, positioning them as a reliable partner for businesses seeking specialized feed solutions in the Southeast Asian region.
Ficocyte
Pegnano
National Phytopharma Joint-Stock Company
🇻🇳 Vietnam
1976501-1000 peopleDistributor/Wholesaler/Trading CompanyEstablished brand
Own brand
Shipments
55
Key customer
VS VIETNAM PHARMACEUTICAL
Key market
🇸🇬 Singapore
Description
National Phytopharma Joint-Stock Company, also known as Công ty Cổ phần Dược liệu Trung ương 2 (Phytopharma), is a premier pharmaceutical distributor and wholesaler based in Ho Chi Minh City, Vietnam. Established in 1976, the company has nearly 50 years of experience and has grown into a leading enterprise with a workforce of 501 to 1,000 employees. It specializes in the import and distribution of a comprehensive range of healthcare products, including pharmaceuticals, vaccines, medical equipment, cosmetics, and traditional medicinal herbs. In 2022, the company achieved a significant revenue of 30,000 billion VND, reflecting its dominant position in the Vietnamese market.
Phytopharma serves as a strategic partner for over 30 global pharmaceutical groups, including industry leaders such as AstraZeneca, Pfizer, Novartis, GSK, Roche, and Bayer. The company operates a sophisticated supply chain infrastructure featuring GSP and GDP standard warehouses in major hubs like Hanoi, Da Nang, and Long An, supported by advanced WMS, ERP, and DMS management software. Beyond distribution, Phytopharma provides specialized B2B services such as warehousing, logistics, customs clearance, product registration, and consulting.
While its core business is pharmaceutical distribution, the company maintains a highly diversified portfolio that includes the export of essential oils and handicrafts, as well as the wholesale of nutritional products and medical instruments. Recognized by Vietnam Report and the VNR500, National Phytopharma Joint-Stock Company is a critical link in Vietnam's healthcare system, ensuring the nationwide availability of high-quality, innovative medicines and healthcare solutions.
Phytopharma Logo
logo
